J. Vertommen

发表

Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations.

A. Müllertz, C. Pouton, C. Porter, 2012, Journal of pharmaceutical sciences.

Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.

A. Müllertz, C. Pouton, C. Porter, 2012, Molecular pharmaceutics.

Divergent effects of different oxidants on glutathione homeostasis and protein damage in erythrocytes from diabetic patients: Effects of high glucose

J. Vertommen, B. M. Keenoy, I. D. De Leeuw, 2001, Molecular and Cellular Biochemistry.

Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitus.

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 2005, Diabetes & metabolism.

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations

A. Müllertz, C. Pouton, C. Porter, 2013, Pharmaceutical Research.

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels

A. Müllertz, C. Pouton, C. Porter, 2014, The AAPS Journal.

Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 2004, Diabetes/metabolism research and reviews.

The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects.

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 1998, Atherosclerosis.

Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes.

J. Vertommen, B. M. Keenoy, I. D. De Leeuw, 2000, The American journal of clinical nutrition.

Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes 1 – 3

J. Vertommen, B. M. Keenoy, I. Leeuw, 2022 .

Effects of pravastatin on lipid levels, in vitro oxidizability of non-HDL lipoproteins and microalbuminuria in IDDM patients.

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 1995, Diabetes research and clinical practice.

The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients.

J. Vertommen, I. D. De Leeuw, B. Manuel y Keenoy, 1999, Diabetes, nutrition & metabolism.

Effects of intravenous supplementation with α-tocopherol in patients receiving total parenteral nutrition containing medium- and long-chain triglycerides

J. Vertommen, I. Leeuw, B. Manuel-y-keenoy, 2002, European Journal of Clinical Nutrition.

Magnesium Status and Parameters of the Oxidant-Antioxidant Balance in Patients with Chronic Fatigue: Effects of Supplementation with Magnesium

J. Vertommen, I. D. De Leeuw, J. Néve, 2000, Journal of the American College of Nutrition.

Magnesium and Oxidative Stress Status in Patients with Chronic Fatigue

J. Vertommen, I. Leeuw, G. Moorkens, 1997 .

Beta‐cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA‐DQ types in type 1 diabetes

J. Vertommen, C. D. De Block, I. D. De Leeuw, 2001, Clinical and experimental immunology.

Time Course of Oxidative Stress Status in the Postprandial and Postabsorptive States in Type 1 Diabetes Mellitus: Relationship to Glucose and Lipid Changes

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 2005, Journal of the American College of Nutrition.

Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitus.

J. Vertommen, I. D. De Leeuw, W. Engelen, 2001, The Journal of nutrition.

Evolution of Serum α‐Tocopherol in the Postprandial and Postabsorptive Phases in Type 1 Diabetes Mellitus

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 2004 .

Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system.

Anette Müllertz, Hywel D Williams, Philip Sassene, 2014, Journal of pharmaceutical sciences.

Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome.

J. Vertommen, I. D. De Leeuw, G. Moorkens, 2001, Life sciences.

Erythrocyte sorbitol content in diabetic patients: relation to metabolic control.

J. Vertommen, I. D. De Leeuw, E. Rillaerts, 1987, Diabete & metabolisme.

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase

Anette Müllertz, Vincent Jannin, Christopher J. H. Porter, 2014, Pharmaceutical Research.

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels

A. Müllertz, C. Pouton, C. Porter, 2014, The AAPS Journal.

The magnesium content of the trabecular bone in diabetic subjects.

J. Vertommen, I. D. De Leeuw, R. Abs, 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin.

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 2004, Atherosclerosis.

Effects of Atorvastatin on LDL sub‐fractions and peroxidation in type 1 diabetic patients: a randomised double‐blind placebo‐controlled study

J. Vertommen, I. D. De Leeuw, C. van Campenhout, 2003, Diabetes/metabolism research and reviews.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Flavonoid treatment reduces glycation and lipid peroxidation in experimental diabetic rats

J. Vertommen, I. D. De Leeuw, M. K. Van den Enden, 1994 .

Oxidative stress status in patients with diabetes mellitus: relationship to diet

J. Vertommen, I. Leeuw, B. Manuel-y-keenoy, 2003, European Journal of Clinical Nutrition.

A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation.

L. V. Van Gaal, J. Vertommen, I. D. De Leeuw, 1994, Clinica chimica acta; international journal of clinical chemistry.

Influence of weight gain and starvation on the blood and tissue levels of magnesium in obese, gold-thioglucose-treated, hyperglycemic mice

J. Vertommen, I. Leeuw, M. D'hollander, 1983 .

A. Müllertz, C. Pouton, C. Porter, 2013, Pharmaceutical Research.

Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects.

Luc Van Gaal, Jan Vertommen, L. V. Van Gaal, 2008, Current diabetes reviews.

Magnesium deficit in a sample of the Belgian population presenting with chronic fatigue.

J. Vertommen, I. D. De Leeuw, G. Moorkens, 1997, Magnesium Research.

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase

A. Müllertz, C. Pouton, C. Porter, 2015, Pharmaceutical Research.

Platelet Prothrombinase Activity, a Final Pathway Platelet Procoagulant Activity, Is Overexpressed in Type 1 Diabetes: No Relationship With Mean Platelet Volume or Background Retinopathy

Z. Berneman, J. Vertommen, I. D. De Leeuw, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

In New‐onset Insulin‐dependent Diabetic Patients the Presence of Anti‐thyroid Peroxidase Antibodies is Associated with Islet Cell Autoimmunity and the High Risk Haplotype HLA DQA1*0301‐DQB1*0302

J. Vertommen, Belgian Diabetes Registry, P. Abrams, 1996, Diabetic medicine : a journal of the British Diabetic Association.

Effect of Statil (ICI 128436) on Erythrocyte Viscosity In Vitro

J. Vertommen, I. D. De Leeuw, Eddy G Rillaerts, 1988, Diabetes.

Erythrocyte sorbitol dehydrogenase activity in diabetic patients.

J. Vertommen, I. D. De Leeuw, E. Rillaerts, 1993, Diabetes research and clinical practice.